Zevra Therapeutics ZVRA
NASDAQ ZVRA
$11.05 -0.29 (-2.56%)
As of: Sep 30, 2026 · 1:21 PM EDT

Zevra Therapeutics, Inc. (ZVRA) Restructuring Costs (2016 - 2020)

Updated

Zevra Therapeutics (ZVRA) posted Restructuring Costs of -$2,000 for Q4 2020.

Analysis

Zevra Therapeutics, Inc. (ZVRA) Restructuring Costs (2016 - 2020) Analysis & Trends

For FY2020, Zevra Therapeutics' Restructuring Costs came in at $828,000.

  • Annual Restructuring Costs shows a four-year compound annual growth rate of -27.6% (FY2016 to FY2020).
  • In prior years, Zevra Therapeutics' Restructuring Costs was $1.64 million in FY2018 and $3.01 million in FY2016.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 -2,000.00
Mar 31, 2020 830,000.00
Sep 30, 2018 1.64 Mn
Sep 30, 2016 3.01 Mn
API Access

Zevra Therapeutics, Inc. Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=ZVRA&period=max&api_key=YOUR_API_KEY